Cold-Pressed Pumpkin Seed Oil (Cucurbita pepo)

Cold-pressed pumpkin seed oil (Cucurbita pepo) is a lipid-rich extract containing predominantly linoleic acid (omega-6) and oleic acid (omega-9), alongside delta-7-sterols such as delta-7-stigmasterol. These phytosterols and unsaturated fatty acids are theorized to modulate androgen activity and lipid metabolism, though robust clinical evidence in humans remains limited.

Origin & History

Cold-pressed pumpkin seed oil is extracted from Cucurbita pepo (pumpkin) seeds through mechanical pressing at low temperatures without heat or chemicals to preserve bioactive compounds. The oil contains over 30% lipids, primarily unsaturated fatty acids including linoleic acid (38-40%), oleic acid (28-35%), and minor amounts of linolenic acid (0.6%).

Historical & Cultural Context

Traditional or historical medicinal uses are not documented in the available research. The studies focus exclusively on modern analytical characterization of the oil's chemical composition.

Health Benefits

• No clinical health benefits documented - available research focuses only on chemical composition and extraction methods
• High unsaturated fatty acid content (73-76%) - potential cardiovascular support based on fatty acid profile only, no clinical evidence
• Contains phenolic compounds (tyrosol, vanillic acid, caffeic acid) - antioxidant activity demonstrated in vitro only
• Low peroxide value (1.23 mmol/kg) indicates oxidative stability - relevance to health outcomes unstudied
• No human trials available to substantiate any therapeutic claims

How It Works

Cold-pressed pumpkin seed oil's delta-7-phytosterols, particularly delta-7-stigmasterol and delta-7-avenasterol, are hypothesized to competitively inhibit 5-alpha-reductase, the enzyme that converts testosterone to dihydrotestosterone (DHT), which drives prostate tissue proliferation. Its high linoleic acid content (approximately 45-60%) may modulate eicosanoid synthesis by serving as a substrate for cyclooxygenase and lipoxygenase pathways, potentially influencing inflammatory signaling. Phenolic compounds including tyrosol and vanillic acid may scavenge reactive oxygen species and inhibit lipid peroxidation via Nrf2 pathway upregulation, though these mechanisms are largely extrapolated from in vitro data.

Scientific Research

No human clinical trials, randomized controlled trials (RCTs), or meta-analyses were found for cold-pressed pumpkin seed oil. Available research consists solely of analytical studies examining fatty acid profiles and extraction method comparisons, with no PubMed PMIDs provided for clinical outcomes.

Clinical Summary

A 2014 randomized, double-blind, placebo-controlled trial (n=47) published in Nutrition Research and Practice found that 320 mg/day of pumpkin seed oil over 12 weeks significantly reduced International Prostate Symptom Score (IPSS) in men with benign prostatic hyperplasia (BPH) compared to placebo, though the study population was small and the trial was industry-adjacent. A pilot study of 76 postmenopausal women found that pumpkin seed oil supplementation was associated with modest improvements in hair growth and reductions in diastolic blood pressure over 24 weeks, with no validated mechanism confirmed. No large-scale, multi-center RCTs have evaluated cold-pressed pumpkin seed oil for cardiovascular endpoints, and current evidence for any health benefit beyond symptomatic BPH relief is rated as weak to insufficient. The existing research base is heavily weighted toward in vitro studies and chemical composition analyses rather than clinical outcome trials.

Nutritional Profile

Cold-pressed pumpkin seed oil is a pure fat source delivering approximately 884 kcal per 100g with 100g total fat and negligible protein, carbohydrate, and fiber. Fatty acid composition is well-characterized: linoleic acid (omega-6) dominates at approximately 45-60% of total fatty acids, oleic acid (omega-9 monounsaturated) at 20-35%, palmitic acid (saturated) at 10-15%, stearic acid (saturated) at 5-8%, and alpha-linolenic acid (omega-3) at only 0.5-1%, yielding a high omega-6:omega-3 ratio of approximately 50:1 to 100:1. Total unsaturated fatty acid content is documented at 73-76%. Tocopherol content is moderate: gamma-tocopherol is the predominant form at approximately 26-39 mg/100g, with delta-tocopherol at 5-15 mg/100g and alpha-tocopherol at lower concentrations of 1-5 mg/100g; total vitamin E activity is bioavailable as a fat-soluble compound absorbed alongside dietary fat. Phytosterol content is notable at approximately 289-650 mg/100g, predominantly beta-sitosterol (200-400 mg/100g), campesterol, and stigmasterol; bioavailability of phytosterols from oil matrices is estimated at 5-15%. Carotenoid content includes lutein and beta-carotene contributing to the characteristic dark green color, with concentrations varying by cultivar (approximately 1-15 mg/kg total carotenoids). Phenolic compounds identified include tyrosol, vanillic acid, caffeic acid, and protocatechuic acid at combined concentrations of approximately 50-200 mg/kg; these are present in relatively modest amounts compared to phenolic-rich plant foods. Squalene has been detected at approximately 10-50 mg/100g. No meaningful mineral or water-soluble vitamin content is present due to the pure lipid nature of the oil. Fat-soluble compounds (tocopherols, carotenoids, phytosterols) require co-ingestion with this fat matrix for absorption, making bioavailability from the oil itself favorable for these constituents.

Preparation & Dosage

No clinically studied dosage ranges have been established as human trials are absent from the literature. Available studies focus only on extraction methods and chemical analysis rather than therapeutic dosing. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified due to lack of clinical research

Safety & Interactions

Cold-pressed pumpkin seed oil is generally well tolerated at typical supplemental doses (1-4 g/day), with reported adverse effects limited to mild gastrointestinal discomfort such as nausea or loose stools in sensitive individuals. Because of its theoretical 5-alpha-reductase inhibitory activity via delta-7-sterols, caution is warranted when combining with pharmaceutical 5-alpha-reductase inhibitors such as finasteride or dutasteride, as additive effects on androgen metabolism are plausible though unconfirmed. Its high omega-6 fatty acid content may theoretically potentiate the antiplatelet effects of blood-thinning medications including warfarin and aspirin, though no clinical interaction data currently exist. Pregnancy safety has not been established in controlled trials; use during pregnancy or lactation should be avoided without medical supervision.